Puma Biotechnology (PBYI) Work In Process (2020 - 2026)

Puma Biotechnology (PBYI) has 7 years of Work In Process data on file, last reported at $1.9 million in Q1 2026.

• Quarterly Work In Process rose 80.36% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 80.36% YoY) and the FY2025 annual result came in at $1.3 million, up 77.18% from the prior year.
• Work In Process improved to $1.9 million in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $7.8 million in Q2 2024 to a low of $758000.0 in Q4 2024.
• A 5-year average of $2.5 million and a median of $2.0 million in 2024 frame the typical range for Work In Process.
• The widest YoY moves for Work In Process: up 169.08% in 2025, down 82.89% in 2025.
• Tracing PBYI's Work In Process over 5 years: stood at $2.7 million in 2022, then plunged by 69.18% to $820000.0 in 2023, then fell by 7.56% to $758000.0 in 2024, then soared by 77.18% to $1.3 million in 2025, then soared by 43.56% to $1.9 million in 2026.
• The last three Work In Process figures came in at $1.9 million (Q1 2026), $1.3 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.